+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States



Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States



Transplantation 102(3): 454-460



Hepatitis C virus (HCV) infection is common among kidney transplant (KTx) recipients. However, the impact of HCV infection on long-term graft and recipient survival after KTx from large-scale data remains to be determined. We used the Organ Procurement and Transplantation Network database to identify all adults undergoing KTx in 2004 to 2006 in the United States. A propensity score was created to match each HCV-positive recipient with an HCV-negative control for unbiased comparisons. Survival analysis was conducted to evaluate recipient and death-censored graft survival. Out of 33 357 adult primary KTx recipients, 1470 (4.4%) were HCV-positive: 1364 HCV-positive and -negative pairs were selected by propensity score matching. Based on multivariable regression models, HCV is associated with a higher risk of death (hazard ratio [HR], 1.50; 95% confidence interval [95% CI], 1.28-1.75) and graft failure (HR, 1.26; 95% CI, 1.08-1.47). Infection was a more common cause of death in HCV-positive patients than in HCV-negative recipients (HR, 1.64; 95% CI, 1.12-2.42). The incidence of death due to liver failure was 0.23% per year among HCV-positive recipients, whereas no HCV-negative recipients died from liver failure. Graft failure due to recurrent disease was higher in HCV-positive than in HCV-negative recipients (HR, 2.00; 95% CI, 1.06-3.78). HCV infection is associated with decreased long-term recipient and graft survival. Future studies are needed to examine whether recently available, safe, and effective antiviral therapy improves the long-term clinical outcome in these patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059927995

Download citation: RISBibTeXText

PMID: 28976413

DOI: 10.1097/tp.0000000000001953


Related references

Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data. Clinical Transplantation 31(10):, 2017

Association of hepatitis C virus infection with mortality and graft survival in kidney-pancreas transplant recipients. Transplantation 64(2): 281-286, 1997

The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients. Experimental and Clinical Transplantation 13(Suppl. 1): 188-192, 2015

Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 65(5): 667-670, 1998

Decreased patient and renal allograft survival in kidney-pancreas transplant recipients with hepatitis C virus infection. Journal of the American Society of Nephrology 7(9): 1924, 1996

Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. Transplantation Proceedings 27(1): 956-957, 1995

Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study. Urology Journal 5(3): 178-183, 2008

Predicting early and long term patient and graft survival for liver transplant recipients with HCV infection Results of the NIDDK liver transplant database. Hepatology 36(4 Part 2): 177A, 2002

B cell crossmatching and early graft survival in United States kidney transplant recipients. Human Immunology 59(Suppl. 1): 120, 1998

Long-term impact of hepatitis B and C virus infection in kidney transplant recipient's survival. Transplantation Proceedings 35(3): 1076-1077, 2003

Long term effect of hepatitis B and C virus infection on the survival of kidney transplant patients. Revista Da Associacao Medica Brasileira 49(4): 389-394, 2003

Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era. Experimental and Clinical Transplantation 12(Suppl. 1): 45-49, 2014

Hypertension and decreased graft survival in long term kidney transplant recipients. Kidney International 27(1): 188, 1985

Predicting long-term graft survival in adult kidney transplant recipients. Saudi Journal of Kidney Diseases and Transplantation 23(4): 693-700, 2012

Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States. Clinical Journal of the American Society of Nephrology 6(6): 1481-1487, 2011